Negative selection and stringency modulation in continuous evolution systems

Patent metadata

Field	Value
Publication number	US-12398390-B2
Application number	US-201916238386-A
Country	US
Kind code	B2
Filing date	Jan 2, 2019
Priority date	Jan 20, 2014
Publication date	Aug 26, 2025
Grant date	Aug 26, 2025

Abstract

Strategies, systems, methods, reagents, and kits for phage-assisted continuous evolution are provided herein. These include strategies, systems, methods, reagents, and kits allowing for stringency modulation to evolve weakly active or inactive biomolecule variants, negative selection of undesired properties, and/or positive selection of desired properties.

First claim

What is claimed is:

1. A vector system comprising: a selection phagemid, a low selection stringency plasmid, and a high selection stringency plasmid, wherein
the low selection stringency plasmid comprises a first nucleic acid encoding a first pIII protein that is operably linked to a small molecule inducible promoter;
the high selection stringency plasmid comprises a second nucleic acid encoding a second pIII protein that is operably linked to an activity-dependent promoter comprising a binding site for a DNA-binding gene product; and
the selection phagemid comprises a third nucleic acid encoding the DNA-binding gene product.

2. The vector system of claim 1 , wherein binding of the DNA-binding gene product to the DNA-binding gene product binding site activates the activity-dependent promoter.

3. The vector system of claim 1 , wherein the small molecule inducible promoter is a drift promoter.

4. The vector system of claim 1 , wherein the low selection stringency plasmid comprises a mutagenesis cassette under the control of a second small-molecule inducible promoter.

5. The vector system of claim 1 , wherein the activity-dependent promoter comprises a T7 promoter.

6. The vector system of claim 3 , wherein the drift promoter is a P psp-tet promoter.

7. The vector system of claim 1 further comprising an E. coli host cell comprising a negative selection gene and a dominant negative mutant gene of a pIII protein.

8. The vector system of claim 1 , wherein the selection phagemid comprises all viral genes required for the generation of viral particles, except for a full-length pIII gene that is required to package the selection phagemid into infectious viral particles.

9. The vector system of claim 7 , wherein the E. coli host cell is of the genotype F′proA+B+Δ(lacIZY) zzf::Tn10 (TetR) lacIQ1 PN25-tetR luxCDE/endA1 recA1 galE15 galK16 nupG rpsL(StrR) ΔlacIZYA araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC) proBA::pir116 araE201 ΔrpoZ Δflu ΔcsgABCDEFG ΔpgaC λ-.

10. The vector system of claim 1 , wherein the DNA-binding gene product is selected from the group consisting of polymerases, transcription factors, nucleases, and methylases.

11. The vector system of claim 10 , wherein the DNA-binding gene product is an RNA polymerase.

12. The vector system of claim 1 , wherein the expression of the pIII protein is required to package the selection viral phagemid into infectious viral particles.

13. The vector system of claim 1 , wherein the pIII protein comprises the amino acid sequence set forth in SEQ ID NO: 9.

14. The vector system of claim 7 , wherein the dominant negative mutant gene of the pIII protein is situated on an accessory plasmid.

15. The vector system of claim 7 , wherein the dominant negative mutant gene of the pIII protein is under the control of a riboswitch.

16. The vector system of claim 15 , wherein the riboswitch is a theophylline-activated riboswitch.

17. The vector system of claim 7 , wherein the negative selection gene comprises a negative selection promoter.

18. The vector system of claim 17 , wherein the negative selection promoter is a T3 or T7 promoter.

19. The vector system of claim 7 , wherein the dominant negative pIII protein comprises any one of the amino acid sequences set forth in SEQ ID NOs.: 10-14.

20. The vector system of claim 18 , wherein the dominant negative pIII protein comprises the amino acid sequence set forth in SEQ ID NO: 10.

Assignees

• Harvard College

Inventors

• Liu David R
• Carlson Jacob Charles
• Badran Ahmed Hussein
• Esvelt Kevin Michael

Classifications

• C12N2830/002

  inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor · CPC title

• C12N2800/40

  Systems of functionally co-operating vectors · CPC title

• C12N2800/101

  for bacteria · CPC title

• C12N2830/60

  from viruses · CPC title

• C12N2795/00041

  Use of virus, viral particle or viral elements as a vector · CPC title